Last verified: 17 days ago
Akkermansia
Also known as: Akkermansia muciniphila, A. muciniphila, Akk
Evidence under review. — Not yet rated
Gut bacterium linked to metabolic health, gut barrier support, and reduced inflammation. Early-stage research.
-
What it does
Akkermansia muciniphila is a naturally occurring gut bacterium that lives in the mucus lining of the intestines. Research suggests it plays a role in maintaining the gut barrier, reducing...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
No established dose
What the Science Says
Akkermansia muciniphila is a naturally occurring gut bacterium that lives in the mucus lining of the intestines. Research suggests it plays a role in maintaining the gut barrier, reducing inflammation, and supporting metabolic health — including blood sugar regulation and body weight. Most human evidence comes from studies measuring Akkermansia levels as a marker of gut health, with direct supplementation research still in early stages.
What It Doesn't Do
Not proven to directly treat or cure any disease. Won't reliably boost its own levels just by taking inulin — one clinical trial found inulin didn't raise Akkermansia levels in type 1 diabetes patients. No strong human evidence it fights cancer on its own. Lab findings on colorectal cancer are cell-study results only, not human trials. Don't expect dramatic weight loss from Akkermansia supplements alone.
Evidence-Based Benefits
Higher Akkermansia levels are associated with better gut barrier integrity and reduced intestinal inflammation.
Weak EvidenceEffective at: No established dose
Supporting studies (click to view on PubMed):
Prebiotic formulas that raise Akkermansia levels may support metabolic markers in overweight adults.
Weak EvidenceEffective at: No established dose
Supporting studies (click to view on PubMed):
Lower Akkermansia levels are causally linked to higher risk of intervertebral disc degeneration in human cohort data.
Weak EvidenceEffective at: No established dose
Supporting studies (click to view on PubMed):
Inactivity reduces Akkermansia in the gut, and this decline is associated with early frailty development in older adults.
Weak EvidenceEffective at: No established dose
Supporting studies (click to view on PubMed):
Absorption & Bioavailability
Unknown — as a live or postbiotic bacterium, survival through the digestive tract depends heavily on formulation (live vs. pasteurized vs. postbiotic). No direct bioavailability data in the provided studies.
Red Flags to Watch For
- Most exciting findings (cancer, disc degeneration) come from animal or cell studies — not human clinical trials
- Inulin supplementation did NOT increase Akkermansia levels in a human pilot study, suggesting prebiotic boosting strategies may not work as marketed
- Only 7 registered supplement products in NIH DSLD — limited regulatory track record
- Postbiotic and live formulations are not equivalent; product labeling may not distinguish between them
- Studies showing benefits often involve Akkermansia as one of many microbiome changes, making it hard to isolate its specific contribution
Frequently Asked Questions
What does Akkermansia do?
Gut bacterium linked to metabolic health, gut barrier support, and reduced inflammation. Early-stage research.
What is the effective dose of Akkermansia?
No established dose
Is Akkermansia safe?
Most exciting findings (cancer, disc degeneration) come from animal or cell studies — not human clinical trials
What doesn't Akkermansia do?
Not proven to directly treat or cure any disease.
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25